Lisa M. Hollier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lisa M. Hollier has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
George D Wendel
UT Southwestern Medical Center; Department of Obstetrics and Gynecology; 5323 Harry Hines Boulevard Dallas TX USA 75390
3 shared publications- George D. Wendel
From the Departments of Obstetrics and Gynecology and Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas
3 shared publications Kimberly Workowski
Division of Infectious Diseases, Emory University, 550 Peachtree Street, Suite 7000, GA 30308, USA; Guidelines Unit, Epidemiology and Surveillance Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Mailstop E-02, 1600 Clifton Road, Atlanta, GA 30333, USA
3 shared publicationsKaren Bishop
University of Texas Houston Medical School, Houston, TX, USA
2 shared publicationsApril L. Ericksen
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX
1 shared publicationCharles C. Kilpatrick
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Medical School at Houston, Houston, TX 77030, USA
1 shared publication
Latest Publications
- Open Access
- 1 March 2009
- Published by SAGE Publications in Women's Health
- Vol. 5 (2) , 165-172
Managing Genital Herpes Infections in Pregnancy
Genital herpes is the leading cause of genital ulcer disease worldwide and it is one of the most common sexually transmitted infections. Genital herpes simplex virus infection during pregnancy poses significant risks, predominantly vertical transmission of infection with resulting neonatal disease. While uncommon, neonatal infection has a high mortality rate and significant long-term morbidity. This article will examine the current recommendations for diagnosis using serologic and viral detection techniques. Treatment options for initial and recurrent genital herpes infection in pregnancy are reviewed. The use of prophylactic antivirals and cesarean delivery are discussed. The article concludes with a look to the future, including potential changes in the management of herpes simplex virus-infected pregnant women.
- 1 March 2009
- Published by SAGE Publications in Women's Health
- Vol. 5 (2) , 165-172
Open AccessManaging Genital Herpes Infections in Pregnancy
Genital herpes is the leading cause of genital ulcer disease worldwide and it is one of the most common sexually transmitted infections. Genital herpes simplex virus infection during pregnancy poses significant risks, predominantly vertical transmission of infection with resulting neonatal disease. While uncommon, neonatal infection has a high mortality rate and significant long-term morbidity. This article will examine the current recommendations for diagnosis using serologic and viral detection techniques. Treatment options for initial and recurrent genital herpes infection in pregnancy are reviewed. The use of prophylactic antivirals and cesarean delivery are discussed. The article concludes with a look to the future, including potential changes in the management of herpes simplex virus-infected pregnant women.
- 31 December 2008
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 22 (4)
Preface
- 31 December 2008
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 22 (4)
Preface
- 31 December 2008
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 22 (4) , 665-691
Treatment of Sexually Transmitted Infections in Women
- 31 December 2008
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 22 (4) , 665-691
Treatment of Sexually Transmitted Infections in Women
- 23 January 2008
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 1,p. CD004946
Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection
Genital herpes simplex virus (HSV) infection is one of the most common viral sexually transmitted infections. The majority of women with genital herpes will have a recurrence during pregnancy. Transmission of the virus from mother to fetus typically occurs by direct contact with virus in the genital tract during birth. To assess the effectiveness of antenatal antiviral prophylaxis for recurrent genital herpes on neonatal herpes and maternal recurrences at delivery. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (January 2007), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2006, Issue 4), MEDLINE (January 1966 to February 2007) and EMBASE (January 1974 to February 2007; handsearched conference proceedings; reviewed bibliographies of all relevant articles for further references; and contacted experts in the field. Randomized controlled trials which assessed the effectiveness of antivirals compared to placebo or no therapy, on neonatal herpes and maternal disease endpoints among pregnant women with genital herpes. Two authors independently applied study selection criteria and extracted data. Seven randomized controlled trials (1249 participants) which met our inclusion criteria compared acyclovir to placebo or no treatment (five trials) and valacyclovir to placebo (two trials). The effect of antepartum antiviral prophylaxis on neonatal herpes could not be estimated. There were no cases of symptomatic neonatal herpes in the included studies in either the treatment or placebo groups. Women who received antiviral prophylaxis were significantly less likely to have a recurrence of genital herpes at delivery (relative risk (RR) 0.28, 95% confidence interval (CI) 0.18 to 0.43, I(2 )= 0%). Women who received antiviral prophylaxis were also significantly less likely to have a cesarean delivery for genital herpes (RR 0.30, 95% CI 0.20 to 0.45, I(2) = 27.3%). Women who received antiviral prophylaxis were significantly less likely to have HSV detected at delivery (RR 0.14, 95% CI 0.05 to 0.39, I(2) = 0%). Women with recurrent genital herpes simplex virus should be informed that the risk of neonatal herpes is low. There is insufficient evidence to determine if antiviral prophylaxis reduces the incidence of neonatal herpes. Antenatal antiviral prophylaxis reduces viral shedding and recurrences at delivery and reduces the need for cesarean delivery for genital herpes. Limited information exists regarding the neonatal safety of prophylaxis. The risks, benefits, and alternatives to antenatal prophylaxis should be discussed with women who have a history and prophylaxis initiated for women who desire intervention.
- 23 January 2008
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 1,p. CD004946
Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection
Genital herpes simplex virus (HSV) infection is one of the most common viral sexually transmitted infections. The majority of women with genital herpes will have a recurrence during pregnancy. Transmission of the virus from mother to fetus typically occurs by direct contact with virus in the genital tract during birth. To assess the effectiveness of antenatal antiviral prophylaxis for recurrent genital herpes on neonatal herpes and maternal recurrences at delivery. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (January 2007), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2006, Issue 4), MEDLINE (January 1966 to February 2007) and EMBASE (January 1974 to February 2007; handsearched conference proceedings; reviewed bibliographies of all relevant articles for further references; and contacted experts in the field. Randomized controlled trials which assessed the effectiveness of antivirals compared to placebo or no therapy, on neonatal herpes and maternal disease endpoints among pregnant women with genital herpes. Two authors independently applied study selection criteria and extracted data. Seven randomized controlled trials (1249 participants) which met our inclusion criteria compared acyclovir to placebo or no treatment (five trials) and valacyclovir to placebo (two trials). The effect of antepartum antiviral prophylaxis on neonatal herpes could not be estimated. There were no cases of symptomatic neonatal herpes in the included studies in either the treatment or placebo groups. Women who received antiviral prophylaxis were significantly less likely to have a recurrence of genital herpes at delivery (relative risk (RR) 0.28, 95% confidence interval (CI) 0.18 to 0.43, I(2 )= 0%). Women who received antiviral prophylaxis were also significantly less likely to have a cesarean delivery for genital herpes (RR 0.30, 95% CI 0.20 to 0.45, I(2) = 27.3%). Women who received antiviral prophylaxis were significantly less likely to have HSV detected at delivery (RR 0.14, 95% CI 0.05 to 0.39, I(2) = 0%). Women with recurrent genital herpes simplex virus should be informed that the risk of neonatal herpes is low. There is insufficient evidence to determine if antiviral prophylaxis reduces the incidence of neonatal herpes. Antenatal antiviral prophylaxis reduces viral shedding and recurrences at delivery and reduces the need for cesarean delivery for genital herpes. Limited information exists regarding the neonatal safety of prophylaxis. The risks, benefits, and alternatives to antenatal prophylaxis should be discussed with women who have a history and prophylaxis initiated for women who desire intervention.
- 30 March 2006
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 55 (5) , 315-320
Comparison of Vaginal Cytokine Collection Methods
The objective of our study was to correlate the interleukin-6 (IL-6) concentrations detected in patient-collected specimens with provider-collected specimens and compare the reproducibility of the methods. All enrolled participants underwent pelvic examination with collection of cytokine samples by the provider and also collected samples themselves using vaginal swabs. The order of sample collection was randomly assigned. All samples were frozen at -80 degrees C for batch analysis. A commercial enzyme-linked immunosorbent assay was used to determine the concentrations of IL-6 in all samples. IL-6 concentrations from wicks and swabs were correlated in a linear fashion (r = 0.67, P < 0.001). IL-6 concentrations in the two swabs (r = 0.94, P < 0.001) and the two wicks (r = 0.71, P < 0.001) were correlated in a linear fashion, although there was more variability in wick specimens. IL-6 concentrations can be reproducibly measured using either method. The ease of patient swab collection and the correlation with provider-collected specimens may make frequent assessment of the vaginal cytokine environment more acceptable to patients.
- 30 March 2006
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 55 (5) , 315-320
Comparison of Vaginal Cytokine Collection Methods
The objective of our study was to correlate the interleukin-6 (IL-6) concentrations detected in patient-collected specimens with provider-collected specimens and compare the reproducibility of the methods. All enrolled participants underwent pelvic examination with collection of cytokine samples by the provider and also collected samples themselves using vaginal swabs. The order of sample collection was randomly assigned. All samples were frozen at -80 degrees C for batch analysis. A commercial enzyme-linked immunosorbent assay was used to determine the concentrations of IL-6 in all samples. IL-6 concentrations from wicks and swabs were correlated in a linear fashion (r = 0.67, P < 0.001). IL-6 concentrations in the two swabs (r = 0.94, P < 0.001) and the two wicks (r = 0.71, P < 0.001) were correlated in a linear fashion, although there was more variability in wick specimens. IL-6 concentrations can be reproducibly measured using either method. The ease of patient swab collection and the correlation with provider-collected specimens may make frequent assessment of the vaginal cytokine environment more acceptable to patients.
- Open Access
- 1 January 2006
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2006 (1) , 57492
Patterns of Antibiotic Resistance Among Group BStreptococcus Isolates: 2001–2004
The objectives were to determine the prevalence of group B streptococcus (GBS) and to characterize antibiotic resistance patterns. All pregnant women presenting to the triage units at two urban hospitals during three intervals from 2001 to 2004 were included. Each interval lasted approximately four weeks. Swabs were inoculated into selective broth and cultured on tryptic soy agar with 5% sheep blood. GBS was identified using the StrepTex latex agglutination system. GBS positive cultures were tested for their resistance to ampicillin, erythromycin, clindamycin, and cefazolin. GBS was isolated from 154 (12.2%) of 1264 swabs collected during the study period. African‐American women were more likely to be colonized with GBS than Caucasians and Hispanics. Resistance to routinely administered antibiotics was common, but there were no statistically significant increases in resistance to antibiotics over the study period. Ongoing surveillance of antibiotic resistance patterns is important in determining optimal prophylaxis and therapy.
- 1 January 2006
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2006 (1) , 57492
Open AccessPatterns of Antibiotic Resistance Among Group BStreptococcus Isolates: 2001–2004
The objectives were to determine the prevalence of group B streptococcus (GBS) and to characterize antibiotic resistance patterns. All pregnant women presenting to the triage units at two urban hospitals during three intervals from 2001 to 2004 were included. Each interval lasted approximately four weeks. Swabs were inoculated into selective broth and cultured on tryptic soy agar with 5% sheep blood. GBS was identified using the StrepTex latex agglutination system. GBS positive cultures were tested for their resistance to ampicillin, erythromycin, clindamycin, and cefazolin. GBS was isolated from 154 (12.2%) of 1264 swabs collected during the study period. African‐American women were more likely to be colonized with GBS than Caucasians and Hispanics. Resistance to routinely administered antibiotics was common, but there were no statistically significant increases in resistance to antibiotics over the study period. Ongoing surveillance of antibiotic resistance patterns is important in determining optimal prophylaxis and therapy.
- 5 August 2005
- Published by Elsevier in Clinics in Perinatology
- Vol. 32 (3)
Infectious Diseases in Pregnancy
- 5 August 2005
- Published by Elsevier in Clinics in Perinatology
- Vol. 32 (3)
Infectious Diseases in Pregnancy
- 5 August 2005
- Published by Elsevier in Clinics in Perinatology
- Vol. 32 (3) , 671-696
Human Herpes Viruses in Pregnancy: Cytomegalovirus, Epstein-Barr Virus, and Varicella Zoster Virus
- 5 August 2005
- Published by Elsevier in Clinics in Perinatology
- Vol. 32 (3) , 671-696
Human Herpes Viruses in Pregnancy: Cytomegalovirus, Epstein-Barr Virus, and Varicella Zoster Virus
- 5 August 2005
- Published by Elsevier in Clinics in Perinatology
- Vol. 32 (3) , 629-656
Treatment of Sexually Transmitted Infections in Pregnancy
- 5 August 2005
- Published by Elsevier in Clinics in Perinatology
- Vol. 32 (3) , 629-656
Treatment of Sexually Transmitted Infections in Pregnancy
- 1 February 2005
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 60 (2) , 124-131
Preventing Preterm Birth: What Works, What Doesn’t
Preterm birth is one of the most important problems in medicine today with an alarming frequency and economic impact. This paper reviews recent research findings specifically addressing the following primary and secondary prevention interventions: cerclage placement, detection and treatment of infections, progesterone administration, antibiotics in preterm labor and the use of tocolysis. The effectiveness of these interventions is presented in terms of the number needed to treat and number needed to harm. At the present, most of our interventions fail to demonstrate benefit in terms of prevention of preterm birth and improvement of neonatal outcomes. Use of progesterone may hold promise, but whether we will develop effective interventions to reduce risks for all women remains to be seen.
- 1 February 2005
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 60 (2) , 124-131
Preventing Preterm Birth: What Works, What Doesn’t
Preterm birth is one of the most important problems in medicine today with an alarming frequency and economic impact. This paper reviews recent research findings specifically addressing the following primary and secondary prevention interventions: cerclage placement, detection and treatment of infections, progesterone administration, antibiotics in preterm labor and the use of tocolysis. The effectiveness of these interventions is presented in terms of the number needed to treat and number needed to harm. At the present, most of our interventions fail to demonstrate benefit in terms of prevention of preterm birth and improvement of neonatal outcomes. Use of progesterone may hold promise, but whether we will develop effective interventions to reduce risks for all women remains to be seen.